• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结直肠癌肝转移的预测模型——我们能否实现个性化治疗及预后?

Predictive models in colorectal liver metastases--can we personalize treatment and outcome?

作者信息

Welsh Fenella K S, Tekkis Paris P, John Timothy G, Rees Myrddin

机构信息

Department of Hepatobiliary Surgery, North Hampshire Hospital, Basingstoke, UK.

出版信息

Dig Surg. 2008;25(6):406-12. doi: 10.1159/000184731. Epub 2009 Feb 12.

DOI:10.1159/000184731
PMID:19212112
Abstract

BACKGROUND/AIMS: Hepatic resection for colorectal liver metastases offers patients the best chance of long-term survival. Survival rates after resection range from 25 to 60%. Predictive models may risk-stratify patients and allow improved selection for surgery or other therapies. This review aims to achieve consensus regarding the predictors of survival after hepatic resection for colorectal metastases and evaluate current predictive models of outcome.

METHODS

A comprehensive literature review of published studies with more than 500 patients describing models for predicting long-term survival in patients undergoing hepatic resection for colorectal metastases.

RESULTS

Five large predictive models have been published to date. The three predictive models developed from the largest series agree over the key independent predictors of poor long-term outcome for patients undergoing liver resection for colorectal metastases. All five models have individual shortcomings, and whilst three have been internally validated, two have been externally validated with conflicting results. The Basingstoke Predictive Index appears to be accurate and internally validated.

CONCLUSIONS

There is need within the international surgical oncology community for consensus regarding a predictive model to be universally adopted for risk-stratifying patients who may benefit from intensive surveillance and selection for adjuvant therapy and clinical trials.

摘要

背景/目的:肝切除治疗结直肠癌肝转移为患者提供了最佳的长期生存机会。切除术后的生存率在25%至60%之间。预测模型可以对患者进行风险分层,从而更好地选择手术或其他治疗方法。本综述旨在就结直肠癌肝转移肝切除术后生存的预测因素达成共识,并评估当前的预后预测模型。

方法

对已发表的研究进行全面的文献综述,这些研究纳入了500多名患者,描述了预测结直肠癌肝转移肝切除患者长期生存的模型。

结果

迄今为止已发表了五个大型预测模型。从最大样本量系列研究中得出的三个预测模型,在结直肠癌肝转移肝切除患者长期预后不良的关键独立预测因素上达成了一致。所有五个模型都有各自的缺点,其中三个模型进行了内部验证,两个模型进行了外部验证,但结果相互矛盾。贝辛斯托克预测指数似乎较为准确且经过了内部验证。

结论

国际外科肿瘤学界需要就一个预测模型达成共识,以便对可能从强化监测以及辅助治疗和临床试验选择中获益的患者进行普遍适用的风险分层。

相似文献

1
Predictive models in colorectal liver metastases--can we personalize treatment and outcome?结直肠癌肝转移的预测模型——我们能否实现个性化治疗及预后?
Dig Surg. 2008;25(6):406-12. doi: 10.1159/000184731. Epub 2009 Feb 12.
2
Chemotherapy prior to hepatic resection for colorectal liver metastases: helpful until harmful?结直肠癌肝转移肝切除术前的化疗:有益还是有害?
Dig Surg. 2008;25(6):421-9. doi: 10.1159/000184733. Epub 2009 Feb 12.
3
Survival after hepatic resection in metastatic colorectal cancer: a population-based study.转移性结直肠癌肝切除术后的生存情况:一项基于人群的研究。
Cancer. 2007 Feb 15;109(4):718-26. doi: 10.1002/cncr.22448.
4
Liver surgery for colorectal metastases: results after 10 years of follow-up. Long-term survivors, late recurrences, and prognostic role of morbidity.结直肠癌肝转移的肝脏手术:10年随访结果。长期生存者、晚期复发及并发症的预后作用。
Ann Surg Oncol. 2008 Sep;15(9):2458-64. doi: 10.1245/s10434-008-9935-9. Epub 2008 May 8.
5
Influence of surgical margin on type of recurrence after liver resection for colorectal metastases: a single-center experience.手术切缘对结直肠癌肝转移灶切除术后复发类型的影响:单中心经验
Surgery. 2008 Mar;143(3):384-93. doi: 10.1016/j.surg.2007.09.038. Epub 2007 Dec 21.
6
Long-term characteristics of 5-year survivors after liver resection for colorectal metastases.结直肠癌肝转移切除术后5年生存者的长期特征
Ann Surg Oncol. 2007 Apr;14(4):1336-46. doi: 10.1245/s10434-006-9071-3. Epub 2007 Jan 18.
7
[Diagnosis and treatment of colorectal liver metastases - workflow].[结直肠癌肝转移的诊断与治疗——工作流程]
Zentralbl Chir. 2008 Jun;133(3):267-84. doi: 10.1055/s-2008-1076796.
8
[Liver resection for non-colorectal, non-neuroendocrine liver metastases--is hepatic resection justified as part of the oncosurgical treatment?].[非结直肠癌、非神经内分泌肝转移瘤的肝切除术——肝切除作为肿瘤外科治疗的一部分是否合理?]
Zentralbl Chir. 2009 Sep;134(5):430-6. doi: 10.1055/s-0029-1224601. Epub 2009 Sep 15.
9
Surgical treatment for extrahepatic recurrence after hepatectomy for colorectal metastases.结直肠癌肝转移肝切除术后肝外复发的外科治疗。
Hepatogastroenterology. 2004 Nov-Dec;51(60):1805-9.
10
Liver resection for colorectal liver metastases in older patients.老年患者结直肠癌肝转移的肝切除术
Crit Rev Oncol Hematol. 2008 Sep;67(3):273-8. doi: 10.1016/j.critrevonc.2008.05.003. Epub 2008 Jul 1.

引用本文的文献

1
Prognostic Factors in Colorectal Liver Metastases: An Exhaustive Review of the Literature and Future Prospectives.结直肠癌肝转移的预后因素:文献综述及未来展望
Cancers (Basel). 2025 Jul 31;17(15):2539. doi: 10.3390/cancers17152539.
2
Oncological outcomes of neoadjuvant chemotherapy in patients with resectable synchronous colorectal liver metastasis: A result from a propensity score matching study.可切除性同步结直肠癌肝转移患者新辅助化疗的肿瘤学结局:一项倾向评分匹配研究的结果
Front Oncol. 2022 Oct 18;12:951540. doi: 10.3389/fonc.2022.951540. eCollection 2022.
3
The Combination of APRI and ALBI Facilitates Preoperative Risk Stratification for Patients Undergoing Liver Surgery After Neoadjuvant Chemotherapy.
APRI 和 ALBI 联合有助于新辅助化疗后行肝切除术患者的术前风险分层。
Ann Surg Oncol. 2019 Mar;26(3):791-799. doi: 10.1245/s10434-018-07125-6. Epub 2019 Jan 7.
4
Recurrence patterns after laparoscopic resection of colorectal liver metastases.腹腔镜结直肠肝转移瘤切除术后的复发模式。
Surg Endosc. 2018 Dec;32(12):4788-4797. doi: 10.1007/s00464-018-6229-6. Epub 2018 May 14.
5
Liver Resection for Non-Colorectal Liver Metastases - Standards and Extended Indications.非结直肠癌肝转移的肝切除术——标准与扩展指征
Viszeralmedizin. 2015 Dec;31(6):394-8. doi: 10.1159/000439419. Epub 2015 Nov 24.
6
Novel methods for clinical risk stratification in patients with colorectal liver metastases.结直肠癌肝转移患者临床风险分层的新方法。
Cancer Res Treat. 2015 Apr;47(2):242-50. doi: 10.4143/crt.2014.066. Epub 2014 Sep 11.
7
The role of 18FDG PET/CT in the management of colorectal liver metastases.18FDG PET/CT 在结直肠癌肝转移管理中的作用。
HPB (Oxford). 2012 Jan;14(1):20-5. doi: 10.1111/j.1477-2574.2011.00378.x. Epub 2011 Nov 14.